Immunization rates of pneumococcal, influenza and tetanus vaccines and knowledge and attitudes of adult patients who receive inpatient treatment at hospital: Point prevalence study
Aziz Ahmad Hamidi, Beray Gelmez Taş, Alper Gündüz, Safiye Nur Çelebi, Elif Serap Esen, Dilek Toprak, İlyas Dökmetaş, Aziz Ahmad Hamidi, Beray Gelmez Taş, Alper Gündüz, Safiye Nur Çelebi, Elif Serap Esen, Dilek Toprak, İlyas Dökmetaş
Abstract
The safety of vaccines, access to health care, the level of community's knowledge and the attention of physicians play a critical role in the rate of adult vaccination. This study aims to determine the immunization rate of pneumococcal, influenza and tetanus vaccines among the patients and their knowledge and attitudes in the hospital. The study is a cross-sectional point prevalence survey. The patients who agreed to participate in the study were interviewed using a questionnaire. Patients' gender, occupation, educational status, income level and risk factors (immunosuppressed and over 65 years old) were compared with the knowledge and attitudes about vaccinations. Of the 251 participants, 51.4% were female and 48.6% were male. The self-reported vaccination rate was 3.5% for pneumococcal, 8.6% for influenza and 26.6% for tetanus. Most of the patients have knowledge about influenza vaccination (90.3%). Patients with the high education level have significantly higher knowlege about tetanus vaccination and higher rate of tetanus vaccine compared to those with low education level (p = 0.04; p = 0.006). It was found that those with higher income levels had the more pneumococcal vaccination, more knowledge on tetanus vaccination, and more attitude that tetanus vaccine is necessary compared to those with lower income level (p < 0.05). Patients without risk factors have a higher rate of tetanus vaccination compared to those with risk factors (p < 0.001). It was inferred that the high level of education and income have a positive effect on the patients vaccination rates and their knowledge and attitude.
Keywords: Adult; Diphtheria-Tetanus Vaccine, Influenza vaccine; Pneumococcal vaccines; immunization.
References
- Maltezou HC, Wicker S, Borg M, Heininger U, Puro V, Theodoridou M, Poland GA. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine. 2011;29:9557−62. doi:10.1016/j.vaccine.2011.09.076. PMID: 21964058.
- Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of vaccination coverage among adult populations – United States, 2015. MMWR SurveillSumm. 2017;66:1−28. doi:10.15585/mmwr.ss6611a1. PMID: 28472027.
- Swanson KA, Schmitt HJ, Jansen KU, Anderson AS. Adult vaccination. Hum Vaccin Immunother. 2015;11:150−5. doi:10.4161/hv.35858. PMID: 25483533
- Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: personalized approaches. Hum Vaccin Immunother. 2017;13:213−15. doi:10.1080/21645515.2016.1234556. PMID: 27669411.
- Centers for Disease Control and Prevention (CDC) Use of 13-valent pneumococcal conjugate vaccineand 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816−9. PMID: 23051612.
- Shields GE, Elvidge J, Davies LM. A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union. BMJ Open. 2017;7:e014847. doi:10.1136/bmjopen-2016-014847. PMID:28601824
- Kim DK, Bridges CB, Harriman KH; Advisory committee on Immunization Practices (ACIP), ACIP Adult Immunization work group Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older – United States, 2016. Am J Transplant. 2016;16:1930−32. doi:10.1111/ajt.13877. PMID: 27197898
- Lee HJ, Choi JH. Tetanus-diphtheria-acellular pertussis vaccination for adults: an update. Clin Exp Vaccine Res. 2017;6:22−30. doi:10.7774/cevr.2017.6.1.22. PMID: 28168170.
- Klett-Tammen CJ, Krause G, Seefeld L, Ott JJ. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health. 2016;16:121. doi:10.1186/s12889-016-2784-8. PMID: 26846202.
- Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H, Icli F. Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members. J BUON. 2013;18:511−5.
- Çelebi Sözener Z, Mısırlıgil M, Çerçi P, Ö Aydın, Kendirlinan R, Sin B, Mısırlıgil Z. Attitudes of adult asthma patients towards influenza vaccination. Tuberk Toraks. 2016; 64:269−74. doi:10.5578/tt.42397. PMID: 28366139.
- Satman I, Akalin S, Cakir B, Altinel S; diaVAXStudyGroup Theeffect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study “diaVAX”. Hum Vaccin Immunother. 2013;9:2618−26. Epub 2013 Jul 25. doi:10.4161/hv.25826. PMID: 23887188.
- Kaufman Z, Green MS. Compliance with influenza and pneumococcal vaccinations in Israel, 1999–2002. Public Health Rev. 2003;31:71−9. PMID: 14656044.
- Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. Active bacterial core surveillance team. N Engl J Med. 2000;342:681−9. doi:10.1056/NEJM200003093421002. PMID: 10706897.
- Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis. 1996;174:752−9. doi:10.1093/infdis/174.4.752. PMID:8843213.
Source: PubMed